U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525947) titled 'A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants' on April 06.
Brief Summary: This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers (HV)
Intervention:
DRUG: JADE101
JADE101 is supplied as sterile solution to be administered by SC injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jade Biosciences, Inc.
Disclaimer: Curated by HT Syndication....